Table 3.

Comparison of change in transaminase levels from baseline to 3 months of follow-up in between two groups.

	Treatment group	Control group	p value∗
SGPT (baseline)	71.56 ± 21.78	64.22 ± 16.09	<0.001
Δ SGPT	28.5 ± 41.8 (median: 29.0)	7.5 ± 48.5 (median: 23.0)	0.007
SGOT (baseline)	61.01 ± 26.05	48.00 ± 15.08	<0.001
Δ SGOT	21.8 ± 34.4 (median: 18.5)	1.2 ± 33.7 (median: 11.0)	<0.001

^∗ Independent t-test. Δ = baseline to 3 months of follow-up. SGPT: serum glutamic pyruvic transaminase; SGOT: serum glutamic-oxaloacetic transaminase.